HTEC
Robo Global® Hlthcare Tech & Innovt ETF
ROBO Gbl Healthcare Tech & Innov PR USD
NAV as of
4 Week: 28.75 - 30.39
52 Week: 26.30 - 34.03
Latest Closing Price
28.89
Premium / Discount
-0.13
Expense Ratio
0.68%
Investment Objective
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | 0.05 | 1.38 | 0.03 |
| 1 Day | 0.51 | 0.00 | 0.00 |
| 1 Week | -2.19 | 3.29 | -0.67 |
| 1 Month | -2.76 | 5.09 | -0.54 |
| 3 Months | -2.02 | 10.22 | -0.20 |
| 6 Months | -1.70 | 16.11 | -0.11 |
| 1 Year | -2.72 | 29.72 | -0.09 |
| 2 Years | -35.19 | 40.38 | -0.87 |
| 3 Years | -1.46 | 47.08 | -0.03 |
| 5 Years | 0.00 | 0.00 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 65.2174 | -0.1456 | -33.5627 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 3.0000 | 75.0000 | 88.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| N.A | ||
Portfolio Data
Total Number of Holdings: 79
Number of Bond Holdings: 0
Number of Equity Holdings: 77
Total Market Value: 93,530,103
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Teladoc Health Inc | 1.8463 | 846 | 0 | 67,976 |
| 2 | Myriad Genetics Inc | 1.7408 | 1,826 | 0 | 64,093 |
| 3 | Natera Inc | 1.7148 | 1,645 | 0 | 63,135 |
| 4 | Align Technology Inc | 1.7079 | 243 | 0 | 62,881 |
| 5 | Penumbra Inc | 1.6740 | 384 | 0 | 61,632 |
| 6 | Abiomed Inc | 1.6643 | 278 | 0 | 61,277 |
| 7 | Arrowhead Pharmaceuticals Inc | 1.6484 | 1,538 | 0 | 60,689 |
| 8 | Siemens Healthineers AG Registered Shares | 1.6212 | 1,274 | 0 | 59,691 |
| 9 | Staar Surgical Co | 1.6057 | 1,693 | 0 | 59,120 |
| 10 | Illumina Inc | 1.6001 | 194 | 0 | 58,914 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 5.36 |
| Large | 23.90 |
| Medium | 31.69 |
| Small | 21.40 |
| Micro | 17.45 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
23.4904
Price/Book*
2.4632
Price/Sales*
3.0575
Price/Cash Flow*
14.9328
Dividend Yield*
0.4257
Growth Measures
Long-Term Earnings
10.9528
Historical Earnings
5.0994
Sales Growth
11.8509
Cash-Flow Growth
-6.8217
Book-Value Growth
12.9836
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
